Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening

Gynecologic Oncology

Volumn 116, Issue 3, 2010, Pages 516-521

  Walsh, Christine S ^a   Blum, Audra ^a   Walts, Ann ^b   Alsabeh, Randa ^b   Tran, Hang ^a   Koeffler, H Phillip ^a,c   Karlan, Beth Y ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Cedars Sinai Medical Center   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Endometrial cancer; Hereditary nonpolyposis colorectal cancer; Lynch syndrome; Microsatellite instability; Mismatch repair; Ovarian cancer

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADULT; ALGORITHM; ARTICLE; CANCER PATIENT; CANCER SCREENING; CONTROLLED STUDY; EARLY CANCER; ENDOMETRIUM CANCER; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METHYLATION; MICROSATELLITE INSTABILITY; OVARY CANCER; PEDIGREE; PREVALENCE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ALGORITHMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA METHYLATION; ENDOMETRIAL NEOPLASMS; FEMALE; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MASS SCREENING; MICROSATELLITE INSTABILITY; MIDDLE AGED; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PROMOTER REGIONS, GENETIC;

EID: 75749143373     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.11.021     Document Type: Article

References (37)

1. Dunlop M.G., Farrington S.M., Carothers A.D., et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum. Mol. Genet. 6 1 (1997) 105-110
2. Aarnio M., Sankila R., Pukkala E., et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int. J. Cancer 81 2 (1999) 214-218
3. Watson P., and Lynch H.T. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71 3 (1993) 677-685
4. Jarvinen H.J., Aarnio M., Mustonen H., et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118 5 (2000) 829-834
5. Vasen H.F., Mecklin J.P., Khan P.M., et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis. Colon. Rectum. 34 5 (1991) 424-425
6. Vasen H.F., Watson P., Mecklin J.P., et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116 6 (1999) 1453-1456
7. Rodriguez-Bigas M.A., Boland C.R., Hamilton S.R., et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J. Natl. Cancer Inst. 89 23 (1997) 1758-1762
8. Umar A., Boland C.R., Terdiman J.P., et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst. 96 4 (2004) 261-268
9. Peltomaki P., and de la Chapelle A. Mutations predisposing to hereditary nonpolyposis colorectal cancer. Adv. Cancer Res. 71 (1997) 93-119
10. Kolodner R.D., Tytell J.D., Schmeits J.L., et al. Germ-line msh6 mutations in colorectal cancer families. Cancer Res. 59 20 (1999) 5068-5074
11. Marra G., and Boland C.R. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J. Natl. Cancer Inst. 87 15 (1995) 1114-1125
12. Vasen H.F., Hendriks Y., de Jong A.E., et al. Identification of HNPCC by molecular analysis of colorectal and endometrial tumors. Dis. Markers 20 4-5 (2004) 207-213
13. Kane M.F., Loda M., Gaida G.M., et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57 5 (1997) 808-811
14. Boland C.R., Thibodeau S.N., Hamilton S.R., et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58 22 (1998) 5248-5257
15. Dietmaier W., Wallinger S., Bocker T., et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res. 57 21 (1997) 4749-4756
16. Salahshor S., Koelble K., Rubio C., et al. Microsatellite instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer. Lab. Invest. 81 4 (2001) 535-541
17. Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J. Mol. Diagn. 10 4 (2008) 293-300
18. Mangold E., Pagenstecher C., Friedl W., et al. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining. J. Pathol. 207 4 (2005) 385-395
19. Berends M.J., Wu Y., Sijmons R.H., et al. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am. J. Hum. Genet. 70 1 (2002) 26-37
20. Kadyrov F.A., Dzantiev L., Constantin N., et al. Endonucleolytic function of MutLalpha in human mismatch repair. Cell 126 2 (2006) 297-308
21. Hampel H., Frankel W.L., Martin E., et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N. Engl. J. Med. 352 18 (2005) 1851-1860
22. Hampel H., Frankel W.L., Martin E., et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J. Clin. Oncol. 26 35 (2008) 5783-5788
23. Peltomaki P., and Vasen H. Mutations associated with HNPCC predisposition-update of ICG-HNPCC/INSiGHT mutation database. Dis. Markers 20 4-5 (2004) 269-276
24. Zhang L. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing. J. Mol. Diagn. 10 4 (2008) 301-307
25. Shia J., Ellis N.A., and Klimstra D.S. The utility of immunohistochemical detection of DNA mismatch repair gene proteins. Virchows Arch. 445 5 (2004) 431-441
26. Mueller J., Gazzoli I., Bandipalliam P., et al. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) Cases. Cancer Res. 69 17 (2009) 7053-7061
27. Jensen L.H., Lindebjerg J., Byriel L., et al. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency. Colorectal Dis. 10 5 (2008) 490-497
28. Loughrey M.B., Waring P.M., Tan A., et al. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Fam. Cancer 6 3 (2007) 301-310
29. Rajagopalan H., Bardelli A., Lengauer C., et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418 6901 (2002) 934
30. Kawaguchi M., Yanokura M., Banno K., et al. Analysis of a correlation between the BRAF V600E mutation and abnormal DNA mismatch repair in patients with sporadic endometrial cancer. Int. J. Oncol. 34 6 (2009) 1541-1547
31. Ewald J., Rodrigue C.M., Mourra N., et al. Immunohistochemical staining for mismatch repair proteins, and its relevance in the diagnosis of hereditary non-polyposis colorectal cancer. Br. J. Surg. 94 8 (2007) 1020-1027
32. Buttin B.M., Powell M.A., Mutch D.G., et al. Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation. Clin. Cancer Res. 10 2 (2004) 481-490
33. Hampel H., Frankel W., Panescu J., et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 66 15 (2006) 7810-7817
34. Berends M.J., Wu Y., Sijmons R.H., et al. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. J. Clin. Oncol. 21 23 (2003) 4364-4370
35. Lu K.H., Schorge J.O., Rodabaugh K.J., et al. Prospective determination of prevalence of Lynch syndrome in young women with endometrial cancer. J. Clin. Oncol. 25 33 (2007) 5158-5164
36. Shannon C., Kirk J., Barnetson R., et al. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium. Clin. Cancer Res. 9 4 (2003) 1387-1392
37. Soliman P.T., Broaddus R.R., Schmeler K.M., et al. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?. J. Clin. Oncol. 23 36 (2005) 9344-9350